The nirC gene in Escherichia coli encodes a specialized membrane protein responsible for nitrite transport across the bacterial cell membrane. Located in the nir operon, which codes for a NADH-dependent nitrite reductase, NirC functions primarily to import nitrite as a substrate for the nitrite reductase enzyme . Unlike related transporters that handle both nitrate and nitrite, NirC is specifically dedicated to nitrite transport, making it a distinct player in bacterial nitrogen metabolism .
Recombinant NirC refers to the artificially produced version of this protein, typically expressed in laboratory settings using genetic engineering techniques for research or commercial purposes. These recombinant proteins maintain the essential structural and functional characteristics of the native protein while allowing for controlled production, purification, and modification.
NirC is a polytopic membrane protein situated in the inner membrane of E. coli cells . The protein consists of 268 amino acids encoded by a gene of 807 base pairs . Structurally, NirC belongs to the formate-nitrite transporter (FNT) family, characterized by its ability to facilitate the movement of small anionic molecules across biological membranes.
The three-dimensional structure of NirC reveals a channel-forming protein that creates a specific pathway for nitrite ions to cross the bacterial membrane. This structural configuration is essential for its selective transport function, allowing it to recognize and transport nitrite while excluding other similar ions.
| Parameter | Description |
|---|---|
| Gene Name | nirC |
| Protein Size | 268 amino acids |
| Gene Length | 807 base pairs |
| Accession IDs | EG10654 (EcoCyc), b3367, ECK3355, P0AC26 (UniProt) |
| Location | Inner membrane |
| Primary Function | Transport of nitrite |
| Family | Formate-nitrite transporter (FNT) family |
Commercially available recombinant NirC proteins typically have a purity level of 85% or greater, as determined by SDS-PAGE analysis . These products serve as valuable tools for structural studies, antibody production, and functional analyses in laboratory settings.
NirC functions as a specialized channel that facilitates the transport of nitrite (NO₂⁻) across the bacterial cell membrane . This transport mechanism serves two critical biological functions: providing nitrite as a substrate for nitrogen metabolism and contributing to cytoplasmic detoxification by managing potentially harmful nitrite concentrations .
The transport function of NirC becomes particularly significant under anaerobic conditions, where nitrite can serve as an alternative electron acceptor in bacterial respiration. By efficiently transporting nitrite into the cell, NirC enables E. coli to utilize this nitrogen compound as part of its metabolic processes, contributing to bacterial survival in oxygen-limited environments.
Research has identified important connections between NirC and other molecular pathways. When the nirC gene is deleted, significant changes occur in related regulatory systems. The stress regulator rpoS and its downstream gene csrA become upregulated, while the diguanylate cyclase gene dgcT is downregulated . These alterations lead to decreased concentration of intracellular 3',5'-cyclic diguanosine monophosphate (c-di-GMP) , a critical second messenger that regulates various bacterial behaviors including biofilm formation and motility.
This regulatory pathway suggests a mechanism by which NirC influences bacterial physiology beyond simple nitrite transport. When NirC is absent, environmental nitrite accumulation triggers nitrite stress, which activates the stress regulator RpoS. This activation leads to changes in c-di-GMP synthesis, ultimately affecting crucial bacterial behaviors like biofilm formation and motility .
The nitrite transporter NirC has emerged as a significant factor in bacterial pathogenicity, particularly in avian pathogenic Escherichia coli (APEC) strains. These strains cause extraintestinal infections in poultry, resulting in substantial economic losses in the poultry industry. Research has demonstrated that NirC influences various aspects of bacterial virulence through multiple mechanisms.
In Salmonella, NirC has been shown to contribute to pathogenicity by downregulating the production of nitric oxide (NO) by host macrophages . This represents a sophisticated mechanism by which bacteria can modulate host immune responses to enhance their survival. While the evidence for this specific mechanism in E. coli is less definitive, the similarities between these bacterial species suggest comparable functions may exist.
| Time Point | Wild-Type APEC | ΔnirC Mutant APEC |
|---|---|---|
| 24 hours post-infection | High mortality | Lower initial mortality |
| 48 hours post-infection | Limited additional mortality | Increasing mortality |
| 7 days post-infection | Similar cumulative mortality | Similar cumulative mortality but reached gradually |
This pattern suggests that NirC affects the kinetics of infection progression rather than the ultimate outcome, pointing to its role in early infection dynamics .
Multiple studies have examined the effects of nirC gene deletion on bacterial physiology and pathogenicity, providing valuable insights into the protein's biological significance. These investigations have revealed surprisingly complex relationships between NirC function and bacterial behaviors.
Contrary to initial expectations, deletion of the nirC gene actually enhances bacterial motility in APEC strains . This increased motility presumably results from the decreased c-di-GMP levels observed in ΔnirC mutants, as c-di-GMP typically acts as a suppressor of bacterial motility.
Conversely, biofilm formation is significantly decreased in NirC-deficient mutants . This reduction aligns with the observed decrease in c-di-GMP levels, as this second messenger normally promotes biofilm development. The altered biofilm formation capability has important implications for bacterial persistence during infection, as biofilms enhance bacterial resistance to host defenses and antimicrobial treatments.
NirC significantly influences bacterial adhesion to host cells. In experimental models, the cell adhesion ability of ΔnirC strains was approximately half that of wild-type bacteria, both in the presence and absence of alpha-D-mannopyranoside . This reduced adhesion capacity suggests that NirC plays a role in the expression or function of bacterial adhesins, the surface proteins that mediate attachment to host cells.
In studies using mouse brain microvascular endothelial cells (b.End3), NirC-deficient mutants demonstrated markedly reduced ability to adhere to these host cells . This finding highlights NirC's potential importance in infections involving the blood-brain barrier, such as bacterial meningitis.
| Tissue | 24 Hours Post-Infection | 48 Hours Post-Infection |
|---|---|---|
| Spleen | Similar counts between WT and ΔnirC | Higher counts in ΔnirC |
| Lung | Similar counts between WT and ΔnirC | Higher counts in ΔnirC |
| Liver | Similar counts between WT and ΔnirC | Higher counts in ΔnirC |
| Macrophages (3 hpi) | Similar counts between WT and ΔnirC | Not applicable |
| Macrophages (16 hpi) | Not applicable | Higher counts in ΔnirC |
These tissue colonization dynamics reveal a complex pattern where NirC-deficient bacteria initially colonize tissues at rates similar to wild-type bacteria but subsequently demonstrate enhanced proliferation or persistence . This pattern suggests that NirC may influence bacterial adaptation to host environments over time, potentially through effects on stress responses or metabolic adaptations.
Recombinant NirC proteins are produced using genetic engineering techniques, typically in E. coli expression systems. These recombinant proteins serve various research and commercial purposes, including structural studies, antibody production, and functional analyses.
Commercial preparations of recombinant NirC typically achieve purity levels of 85% or greater, as determined by SDS-PAGE analysis . These purified proteins enable detailed biochemical and structural studies that would be difficult to conduct with native membrane proteins isolated directly from bacterial cells.
The production of recombinant NirC typically involves:
Cloning the nirC gene into an expression vector
Transforming the construct into a suitable host strain
Inducing protein expression under controlled conditions
Extracting and purifying the recombinant protein using chromatographic techniques
Verifying protein identity and purity through analytical methods
Research applications of recombinant NirC include:
Structure-function studies to identify critical protein domains
Development of inhibitors that could target bacterial nitrite transport
Production of antibodies for detection and localization studies
Analysis of protein-protein interactions with other bacterial or host proteins
E. coli possesses multiple transport systems for nitrogen compounds, with NirC being specifically dedicated to nitrite transport. In contrast, related transporters like NarK and NarU demonstrate broader specificity, handling both nitrate and nitrite . This specialization of NirC suggests evolutionary adaptation for efficient management of nitrite, which can be both a metabolic resource and a potential toxin.
During exponential growth, NarK is approximately 100 times more abundant than NarU in membrane fractions, though this ratio changes to about 10:1 during stationary phase . The relative abundance of NirC compared to these transporters is not explicitly stated in the available research, but its specialized function highlights its distinct role in bacterial physiology.
Functional studies suggest that NarK might operate as a primary nitrate-nitrite antiporter . After nitrate is imported and reduced to nitrite, some nitrite is expelled from the cell and then reimported for reduction to ammonia, likely involving NirC in this reimportation step. This interdependence of different nitrogen transport systems points to a coordinated network for nitrogen compound management.
KEGG: ecj:JW3330
STRING: 316385.ECDH10B_3543
NirC is a membrane protein belonging to the formate/nitrite transporter (FNT) family (transporter class 2.A.44) that functions primarily as a nitrite channel in enteric bacteria. In Escherichia coli and Salmonella typhimurium, NirC is encoded by the third gene of the nirBDCcysG operon. The primary physiological role of NirC is to import nitrite from the periplasm into the cytoplasm, where it can be reduced by the cytoplasmic nitrite reductase NirBD. Electrophysiological studies have confirmed that NirC acts as a voltage-independent specific channel for nitrite anions. While it can transport both nitrite and formate, it shows approximately 30% higher permeability for nitrite compared to formate, which is its physiological cargo .
NirC expression in E. coli is regulated by three key transcription factors:
FNR (Fumarate and Nitrate Reductase) - activated under anoxic conditions
NarL - stimulated by nitrate
NarP - stimulated by both nitrate and nitrite
This regulatory network ensures that NirC is expressed under appropriate environmental conditions, particularly in anoxic environments where nitrate/nitrite respiration becomes important for bacterial metabolism .
Optimizing recombinant NirC expression requires attention to several factors:
N-terminal sequence optimization: The nucleotides immediately following the start codon significantly influence protein expression levels. Using directed evolution-based methodologies to screen large libraries of diversified N-terminal sequences can substantially increase expression levels.
Fusion tags: Consider C-terminal GFP fusion for monitoring expression levels and facilitating fluorescence-activated cell sorting (FACS) to identify high-expressing clones.
Expression vector selection: Choose vectors with appropriate promoters and ribosome binding sites compatible with membrane protein expression.
Host strain selection: Select E. coli strains optimized for membrane protein expression.
Induction conditions: Optimize temperature, inducer concentration, and induction timing to maximize yield of properly folded protein.
Implementing a directed evolution approach with FACS-based selection of N-terminal coding sequences has been shown to increase soluble protein yields by up to 30-fold for various recombinant proteins .
Monitoring recombinant NirC expression and functionality can be accomplished through multiple approaches:
Expression monitoring:
GFP fusion for fluorescence-based detection and quantification
Western blotting with anti-NirC or anti-tag antibodies
Mass spectrometry for protein identification and quantification
Functionality assessment:
Liposome reconstitution: Reconstitute purified NirC into liposomes and measure nitrite transport using fluorescent probes or radioactive tracers.
Electrophysiology: Perform patch-clamp recordings on proteoliposomes or planar lipid bilayers containing NirC to measure channel conductance and ion selectivity.
Complementation assays: Transform NirC-deficient E. coli strains with the recombinant NirC and assess growth under nitrite-dependent conditions.
For electrophysiological assessment, single-channel currents can be determined at asymmetric nitrite concentrations (e.g., 20 mM/100 mM) across different holding potentials to confirm channel functionality .
When investigating NirC structure-function relationships, follow these experimental design principles:
Define your variables clearly:
Independent variables: Mutations/modifications to NirC sequence, expression conditions
Dependent variables: Protein expression level, solubility, transport activity, substrate specificity
Control variables: Expression system, purification method, measurement conditions
Formulate specific, testable hypotheses about how structural changes affect function
Design systematic mutagenesis strategies:
Alanine-scanning mutagenesis of conserved residues
Domain swapping with related transporters
Site-directed mutagenesis of putative substrate binding sites
Implement appropriate controls:
Wild-type NirC as positive control
Empty vector as negative control
Related transporters (e.g., FocA) for specificity comparisons
Plan robust measurement methods for both expression and function
To investigate NirC selectivity between nitrite and formate, consider these methodological approaches:
Bi-ionic potential measurements: Assess reversal potential shifts under bi-ionic conditions (presence of both formate and nitrite) to calculate relative permeabilities.
Competition assays: Measure nitrite transport in the presence of varying formate concentrations to determine competitive inhibition constants.
Site-directed mutagenesis: Modify putative selectivity filter residues based on structural comparisons with FocA (which has opposite selectivity preference) and measure changes in substrate preference.
Structural studies: Use X-ray crystallography or cryo-EM to determine NirC structure in the presence of different substrates.
Electrophysiological studies have shown that while NirC can transport both anions, it exhibits approximately 30% higher permeability for nitrite compared to formate. This is the opposite pattern observed in FocA, where nitrite passes with only 70% of the permeability for formate .
Directed evolution can be applied to engineer NirC for enhanced properties through this methodological workflow:
Library generation:
Create diverse NirC variant libraries using error-prone PCR, DNA shuffling, or targeted mutagenesis of N-terminal sequences
Clone libraries into expression vectors with C-terminal GFP fusion to enable fluorescence-based screening
High-throughput screening:
Transform libraries into appropriate E. coli strains
Use FACS to isolate cells with increased fluorescence, indicating higher expression levels
For functional screening, develop nitrite-responsive fluorescent assays
Iterative selection:
Recover DNA from high-performing variants
Subject to further rounds of mutagenesis and selection
Combine beneficial mutations through DNA shuffling
Characterization and validation:
Analyze sequence changes in improved variants
Perform detailed functional characterization
Validate improvements in different expression conditions
This approach has demonstrated success in increasing soluble recombinant protein yields by up to 30-fold in E. coli through optimization of N-terminal coding sequences .
Research involving recombinant NirC in E. coli must adhere to established regulatory frameworks:
NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules:
Compliance is mandatory for institutions receiving NIH funding
Experiments must be registered through appropriate institutional biosafety channels
Some experiments may require Institutional Biosafety Committee (IBC) approval prior to initiation
Risk assessment considerations:
NirC's role in nitrite transport relates to bacterial adaptation to anaerobic environments
Assess potential impacts on bacterial pathogenicity or survival
Consider whether engineered NirC could confer selective advantages
Documentation requirements:
Maintain detailed records of cloning strategies, host strains, and experimental designs
Document biosafety containment measures appropriate to the risk assessment
Specific approval requirements:
Membrane proteins like NirC often present solubility challenges. These methodological approaches can help:
Fusion partners:
Thioredoxin A (TrxA) fusion to enhance solubility
Glutathione S-transferase (GST) for improved solubility and affinity purification
Maltose-binding protein (MBP) to enhance folding and solubility
N-terminal sequence optimization:
Screen N-terminal coding DNA libraries using FACS-based selection
Optimize the first 10-15 codons following the start codon to enhance translation efficiency
Expression conditions optimization:
Lower induction temperature (16-25°C)
Reduce inducer concentration
Use specialized E. coli strains designed for membrane protein expression
Detergent screening:
Systematically test different detergents for extraction and purification
Consider mild detergents like DDM, LMNG, or CHAPS
Lipid supplementation:
Add specific lipids during purification to maintain protein stability
Consider nanodiscs or other lipid-based systems for functional studies
The FACS-based selection of N-terminal coding sequences has demonstrated success in increasing soluble protein yields up to 30-fold for challenging recombinant proteins .
Distinguishing recombinant NirC function from endogenous transporters requires careful experimental design:
Genetic approaches:
Use NirC knockout strains as expression hosts
Create strains with knockouts of multiple nitrite transporters (NirC, NarK, NarU)
Complement knockout strains with modified NirC variants
Biochemical discrimination:
Incorporate affinity or epitope tags for selective purification/detection
Use site-directed mutagenesis to introduce specific inhibitor sensitivity
Develop NirC-specific antibodies for immunological detection
Functional discrimination:
Heterologous expression:
Express NirC in organisms lacking nitrite transport systems
Use eukaryotic expression systems where bacterial transporters are absent
Engineered NirC has several potential applications in synthetic biology:
Nitrite biosensors:
Development of whole-cell biosensors for environmental nitrite detection
Creation of nitrite-responsive genetic circuits using NirC-mediated nitrite sensing
Metabolic engineering:
Enhancing nitrite uptake for improved nitrogen metabolism in engineered strains
Incorporating NirC into synthetic pathways for nitrite utilization
Protein engineering platforms:
Using NirC as a model system for membrane protein engineering
Developing novel directed evolution approaches for membrane transporters
Bioremediation applications:
Engineering bacteria with enhanced nitrite uptake for nitrite-contaminated water treatment
Developing co-cultures with complementary nitrogen metabolism capabilities
Fundamental membrane protein research:
Using NirC as a model system to explore membrane protein folding and assembly
Investigating the evolutionary relationships within the FNT family
When comparing NirC expression across E. coli strains, consider these methodological approaches:
Systematic strain comparison:
Test expression in common laboratory strains (BL21(DE3), C41(DE3), C43(DE3), etc.)
Compare with specialized membrane protein expression strains
Assess strains with different protease profiles and chaperone levels
Quantitative assessment methods:
Western blotting with standard curves for quantification
Flow cytometry analysis of GFP-fused constructs
Mass spectrometry-based quantification
Functionality assessment across strains:
Nitrite uptake assays in whole cells
Membrane vesicle transport assays
Complementation of NirC-deficient phenotypes
This comparative data can be presented in a table format:
| E. coli Strain | Expression Level | Soluble Fraction | Transport Activity | Notes |
|---|---|---|---|---|
| BL21(DE3) | +++ | + | ++ | High expression but low solubility |
| C41(DE3) | ++ | ++ | +++ | Balanced expression and solubility |
| C43(DE3) | ++ | +++ | +++ | Optimized for membrane proteins |
| Lemo21(DE3) | ++ | +++ | +++ | Tunable expression system |
| Rosetta(DE3) | +++ | + | + | Supplies rare tRNAs |